Biography
During her time at the FTC, Jasmine was an Attorney Advisor to Commissioner Noah Phillips where she provided counsel on policy questions, merger challenges, and conduct investigations, including Edgewell/Harry’s, and Evonik/PeroxyChem, among others. Jasmine also served as counsel to three Directors of the Bureau of Competition where she advised on pending merger and conduct matters involving diverse legal questions such as buyer power, vertical mergers, failing firm defenses, so-called litigating the fix, state action doctrine, and potential and nascent competition. As a lead attorney in the FTC’s Mergers I Division, she spearheaded large investigations and negotiated numerous consent decrees, including Pfizer/Mylan, FTC v. Mallinckrodt, Teva/Allergan, and Thermo Fisher Scientific/Life Technologies, among others. Jasmine has also litigated in the FTC’s administrative court in FTC v. Benco Dental. She received the agency’s Catherine Moscatelli Mentoring Award for her leadership and mentorship of fellow staff attorneys at the Commission.
In her role at Amazon, Jasmine led strategy throughout the lifecycle of competition regulatory matters and private litigations. Over her tenure at the company, she advised on a number of major acquisitions and successful litigations, including Amazon’s acquisitions of MGM, One Medical, and iRobot, and in DiFederico v. Amazon, Wells v. Amazon, and District of Columbia v. Amazon. Jasmine also provided practical and actionable counseling guidance on cutting-edge antitrust topics. Her experience in the technology and other key industry sectors provides clients with unmatched expertise into industries that have received intense antitrust scrutiny in recent years.
During law school, Jasmine served as a Judicial Intern to Judge Richard Roberts in the U.S. District Court for the District of Columbia.
Firm News & Announcements, Speaking Engagements, Latest Thinking
Firm News & Announcements
- Weil Bolsters Antitrust Team with Distinguished Tech Lawyer, FTC Veteran Jasmine Rosner Press Release — September 16, 2024
Speaking Engagements
-
Expanding merger control tools for non-traditional deals and non-traditional theories of harm
Speaker(s):
Jasmine Rosner
November 12, 2024 — Weil Antitrust partner Jasmine Rosner spoke on a panel at GCR’s 2024 Women in Antitrust conference. Panelists discussed how to navigate minority investments, roll-ups, serial acquisitions and hiring of teams as agencies get more aggressive and companies are rethinking their approach.
Latest Thinking
- Antitrust Enforcement in Trump’s Second Term: Policy Changes, Enforcement Priorities, and Leadership Turnover Alert — Antitrust — By Megan A. Granger, Adam C. Hemlock, Eric S. Hochstadt, Brianne Kucerik, Michael Moiseyev, Jeffrey H. Perry, Jasmine Rosner, Kristin Sanford, John E. Scribner, Mark Seidman and Jeff L. White — PDF — November 18, 2024
- New HSR Rules, and Impact of Change in Administration Alert — Antitrust — By Megan A. Granger, Adam C. Hemlock, Eric S. Hochstadt, Brianne Kucerik, Michael Moiseyev, Jeffrey H. Perry, Jasmine Rosner, Kristin Sanford, John E. Scribner, Mark Seidman, Jeff L. White, Carla A. R. Hine and Michael C. Naughton — PDF — November 14, 2024